To date, SNPs in the NLRP3 inflammasome-related genes have been found to act as predictors for survival of patients with chronic myeloid leukemia and non-small cell lung cancer [24, 25], but the role of these SNPs in survival of HCC is still unclear. This evidence concerns the gene NLRP3 and hepatocellular carcinoma.